Skip to main content
CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.132
0.00 (0.00%)
At close: Apr 28, 2026

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had revenue of $3.08M in the quarter ending September 30, 2025, a decrease of -60.54%. This brings the company's revenue in the last twelve months to $26.85M, up 21.72% year-over-year. In the year 2024, CASI Pharmaceuticals had annual revenue of $28.54M, down -15.77%.

Revenue (ttm)
26.85M
Revenue Growth
+21.72%
P/S Ratio
0.10
Revenue / Employee
115.22K
Employees
233
Market Cap
2.71M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.54M-5.34M-15.77%
Dec 31, 202333.88M-9.23M-21.41%
Dec 31, 202243.11M12.94M42.89%
Dec 31, 202130.17M15.03M99.25%
Dec 31, 202015.14M11.01M266.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vaccinex 601.00K
AXIM Biotechnologies 92.90K
Avenue Therapeutics 1.40M
Oncology Pharma 10.21K
Enzolytics 46.59K
GPL Holdings 376.54K
Revenue Rankings

CASI Pharmaceuticals News

More News